Clinical Trial Details

Trial ID: L0954
Source ID: IRCT201105084849N2
Associated Drug: Metformin
Title: The comparison of metformin, pioglitazon and Silymarin on biochemical indices in patient with nonalcoholic fatty liver
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Nutritional and metabolic disorders in diseases classified elsewhere. <br>Nutritional and metabolic disorders in diseases classified elsewhere;Nutritional and metabolic disorders in diseases classified elsewhere
Interventions: Intervention 1: administration of 500mg metformin daily for 2 months. Intervention 2: administration of 15mg pioglitazone daily for 2 months. Intervention 3: administration of 140mg silymarin daily for 2 months.;Treatment - Drugs;Treatment - Drugs;Treatme
Outcome Measures: FBS. Timepoint: 2 months after first measuring. Method of measurement: blood sampling.ALT. Timepoint: 2 months after first measuring. Method of measurement: blood sampling.
Sponsor/Collaborators: Vice-Cancellor for Research of Qazvin University of Medical Science
Gender: All
Age: no limitno limit
Phases: Phase 3
Enrollment: 66
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
Start Date: 28/05/2011
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/5186